clorgyline has been researched along with Invasiveness, Neoplasm in 1 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satram-Maharaj, T | 1 |
| Nyarko, JN | 1 |
| Kuski, K | 1 |
| Fehr, K | 1 |
| Pennington, PR | 1 |
| Truitt, L | 1 |
| Freywald, A | 1 |
| Lukong, KE | 1 |
| Anderson, DH | 1 |
| Mousseau, DD | 1 |
1 other study available for clorgyline and Invasiveness, Neoplasm
| Article | Year |
|---|---|
The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Topics: beta Catenin; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Clor | 2014 |